Trial intelligence / Profile preview

Fenoldopam and renal insufficiency in post-cardiac surgery patients

2007-003045-33Phase 3Terminated

Sponsor
IRCCS Ospedale San Raffaele
Start
Jul 2007
Modality
Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in acute kidney failure (AKF) and renal and urinary disorders comparing Fenoldopam with Placebo (2 arms). Primary endpoint: Prevention of renal replacement therapy. Started Jul 2007; status: terminated.

02

Drugs

fenoldopam
03

Conditions

acute kidney failure (AKF)renal and urinary disorders

Beyond the preview

Go deeper on 2007-003045-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003045-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call